PORTFOLIO MANAGEMENT & REGULATORY AFFAIRS LEADERSHIP

Yaminah Leggett-Wells, MS, MBA, PMP
Senior Director of Project Management

Yaminah brings more than 15 years in leading teams and overseeing programs throughout the drug development lifecycle.  Most recently, Yaminah was Director of Biologics Project Management at MedImmune, including responsibility in the development of Fasenra.  Prior to joining MedImmune, she worked at ICON plc where she assisted in growing and strengthening the project management and clinical pharmacology unit operations globally,  Yaminah is a certified project management professional (PMP) and holds a MS in Pharmacology from Howard University and MBA from Johns Hopkins University.

Lisa Pitt, PharmD, MSJ
Senior Director, Head of Regulatory Affairs

Lisa brings two decades of Drug Development and Global Regulatory Affairs expertise from preclinical through post-marketing phases across multiple therapeutics areas.  Most recently, Lisa served as Vice President, Global Regulatory Affairs at Premier Research leading the strategic regulatory affairs services group.  Prior to that, Lisa has worked at the Food and Drug Administration (FDA), AstraZeneca/MedImmune, PAREXEL Consulting and Novartis Pharmaceuticals Corporation.  Lisa has received a PharmD from the University of Maryland at Baltimore and a MS in Jurisprudence in Health Law and Policy from the Seton Hall University School of Law.